arcturus therapeutic

arcturus therapeutic

ARCT:US

Chart

Detailed Quote

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19.
Featured Articles and Interviews
Two vials labelled "H5N1 Vaccine." One stands and one lays on its side behind the first.

Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines

Press Releases

Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis

Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference

Arcturus Therapeutics Announces First Quarter 2026 Financial Results and Pipeline Progress

The Conversation (0)